Evidence map›Paper›PMID 38502859›Full record

ArticleCancer research2024

Oncogenic Cell Tagging and Single-Cell Transcriptomics Reveal Cell Type-Specific and Time-Resolved Responses to Vhl Inactivation in the Kidney.

Samvid Kurlekar, Joanna D C C Lima, Ran Li, Olivia Lombardi, Norma Masson, Ayslan B Barros, Virginia Pontecorvi, David R Mole, Christopher W Pugh, Julie Adam and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Samvid Kurlekar *Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-1633-1827
Joanna D C C Lima *Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.ORCID 0000-0001-6804-8666
Ran LiNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-4095-424X
Olivia LombardiNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-2376-4092
Norma MassonNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-9714-905X
Ayslan B BarrosNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-0350-6544
Virginia PontecorviNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-3976-2291
David R MoleNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-0984-300X
Christopher W PughNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-5170-1662
Julie AdamNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-7980-7151
Peter J RatcliffeNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-2853-806X
University of Oxford · GBThe Francis Crick Institute · GB

Funding

Ludwig Institute for Cancer Research (LICR)Wellcome Trust FC001501
6 · The paper itself

Abstract

Defining the initial events in oncogenesis and the cellular responses they entrain, even in advance of morphologic abnormality, is a fundamental challenge in understanding cancer initiation. As a paradigm to address this, we longitudinally studied the changes induced by loss of the tumor suppressor gene von Hippel Lindau (VHL), which ultimately drives clear cell renal cell carcinoma. Vhl inactivation was directly coupled to expression of a tdTomato reporter within a single allele, allowing accurate visualization of affected cells in their native context and retrieval from the kidney for single-cell RNA sequencing. This strategy uncovered cell type-specific responses to Vhl inactivation, defined a proximal tubular cell class with oncogenic potential, and revealed longer term adaptive changes in the renal epithelium and the interstitium. Oncogenic cell tagging also revealed markedly heterogeneous cellular effects including time-limited proliferation and elimination of specific cell types. Overall, this study reports an experimental strategy for understanding oncogenic processes in which cells bearing genetic alterations can be generated in their native context, marked, and analyzed over time. The observed effects of loss of Vhl in kidney cells provide insights into VHL tumor suppressor action and development of renal cell carcinoma. SIGNIFICANCE: Single-cell analysis of heterogeneous and dynamic responses to Vhl inactivation in the kidney suggests that early events shape the cell type specificity of oncogenesis, providing a focus for mechanistic understanding and therapeutic targeting.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsSingle-Cell AnalysisVon Hippel-Lindau Tumor Suppressor ProteinAnimalsCarcinogenesisCell ProliferationHumansKidneyMiceTranscriptomeVHL protein, mouseVon Hippel-Lindau Tumor Suppressor Protein

Identifiers

PMID38502859
PMCPMC11148546
OpenAlexW4392939055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.